Diagnostics

Plasma p-Tau181 and p-Tau231 offer complementary information in Alzheimer’s

Diagnosing dementia in low educated and indigenous populations

Antibodies as research tools to study dementia

Microglia associated with longevity and a lower AD risk

The development of oligomer-specific antibodies and their potential use as a diagnostic tool

Hopes and challenges in AD research

The impact of antibodies use on biomedical research

The benefits of GWAS in understanding Alzheimer’s disease

Defining Alzheimer’s disease: clinical or biological

The role of phosphorylated tau in clinical trials

Using phosphorylated tau as a diagnostic tool for Alzheimer’s disease

Neurovascular dysfunction and Alzheimer’s disease pathology

Vascular abnormalities as a predictive precursor for Alzheimer’s disease

The importance of concordant treatment for Alzheimer’s disease and vascular health

Atypical presentation of Alzheimer’s disease in younger patients

Can we predict the onset of Alzheimer’s disease using blood tests?